Comparative efficacy and safety of first-line treatments for advanced hepatocellular carcinoma: a Bayesian network meta-analysis - Top-Institutions - MDSpire

Comparative efficacy and safety of first-line treatments for advanced hepatocellular carcinoma: a Bayesian network meta-analysis

By
Yun Su
Tongze Cai
Jingxuan Wei
Qiuju Huang
Chun Yao
Lei Fu
Jinghui Zheng
Hongwei Guo
Xiongbin Gui
June 5, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Oncology
- Hepatology
#2

Memorial Sloan Kettering Cancer Center

New York, New York
Key Differentiators
- Oncology
#3

Mayo Clinic Cancer Center

Rochester, Minnesota
Key Differentiators
- Oncology
#4

Imperial College London

London, England
Key Differentiators
- Oncology
#5

The Royal Marsden Hospital

London, England
Key Differentiators
- Oncology

Original Source(s)

Frontiers In Immunology

Comparative efficacy and safety of first-line treatments for advanced hepatocellular carcinoma: a Bayesian network meta-analysis

by Yun Su, Tongze Cai, Jingxuan Wei, Qiuju Huang, Chun Yao, Lei Fu, Jinghui Zheng, Hongwei Guo, Xiongbin Gui
June 5, 2026

Related Content

Frontiers In Oncology

Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study

Frontiers In Medicine

Monomorphic epitheliotropic intestinal T-cell lymphoma presenting as acute small intestinal perforation: a case report and exploratory BCL-2–targeted therapy

by Meijuan He, Yao Zhou, Jia Yao, Qiu Zhang, Wenjing Xu, Xiaoping Ye, Yihan Cai, Zefa Liu
June 5, 2026

Frontiers In Oncology

Lobectomy versus sublobar resection for stage I non-small cell lung cancer: an umbrella review of evidence quality, overlap, surgical-extent heterogeneity, and survival outcomes

by Xiang Lin, Jingwen Zhang, Beinuo Wang, Zhenghao Dong, Yu Tong, Jian Zhou, Hu Liao
June 5, 2026